ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,090.27
      0.25%
      US Tech 100
      21,038.00
      0.79%
      Dow Jones
      44,642.52
      -0.28%
      Brent Oil
      70.95
      0.00%
      Bitcoin
      100,409.83
      0.49%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Medicenna Therapeutics Corp (MDNA) Quote

      Medicenna Therapeutics Corp

      Medicenna Therapeutics Corp (MDNA)

      TSX
      1.96
      -0.03
      (-1.51%)
      Closed December 07 4:12PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.96
      Bid
      1.90
      Ask
      1.96
      Volume
      78,538
      1.86 Day's Range 2.01
      0.38 52 Week Range 2.98
      Market Cap
      136.489M
      Previous Close
      1.99
      Open
      2.01
      Last Trade
      51
      @
      1.96
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      82,727
      Shares Outstanding
      69,637,000
      Dividend Yield
      -
      PE Ratio
      -5.33
      Earnings Per Share (EPS)
      -0.37
      Revenue
      -
      Net Profit
      -25.47M

      About Medicenna Therapeutics Corp

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.medicenna.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      -
      Medicenna Therapeutics Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker MDNA. The last closing price for Medicenna Therapeutics was $1.99. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.38 to $ 2.98.

      Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $138.58 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -5.33.

      Ask ADVFN Intelligence (AI)

      MDNA Latest News

      More News

      Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

      70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination with Merck’s (known as MSD outside of the US and...

      December 05 2024
      GlobeNewswire Inc.

      Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference

      TORONTO and HOUSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...

      November 27 2024
      GlobeNewswire Inc.

      Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)

      MDNA11 shows significant survival benefits in preclinical glioblastoma models, expanding CD8+ T and NK cells Bizaxofusp selectively targets human tumor cells and immune-suppressive cells...

      November 25 2024
      GlobeNewswire Inc.

      Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update

      MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression...

      November 15 2024
      GlobeNewswire Inc.

      Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO) and the 2024 San Antonio Breast Cancer Symposium (SABCS)

      TORONTO and HOUSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...

      November 13 2024
      GlobeNewswire Inc.

      Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC

      Single-agent MDNA11 shows a 30% objective response rate (3 of 10) in the monotherapy dose expansion cohort among patients with advanced and/or metastatic solid tumors who had disease progression...

      November 11 2024
      GlobeNewswire Inc.

      Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

         MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT (Bifunctional SuperKine for ImmunoTherapy), engineered to deliver an anti-PD1-IL-2 Superkine (anti-PD1-IL-2SK) to the tumor...

      November 08 2024
      GlobeNewswire Inc.

      OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX

      NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Medicenna...

      October 15 2024
      GlobeNewswire Inc.

      Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

      Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumors Preclinical data on MDNA113, Medicenna's first-in-class...

      October 04 2024
      GlobeNewswire Inc.

      Medicenna Announces Results of Annual Meeting of Shareholders

      TORONTO and HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on...

      September 26 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.168.888888888891.82.141.6899611.8730083CS
      4-0.5-20.3252032522.462.591.271236371.81379761CS
      12-0.1-4.854368932042.062.621.27827272.00206968CS
      26-0.44-18.33333333332.42.631.27837922.06928731CS
      521.465295.959595960.4952.980.381017911.83451848CS
      156-0.07-3.448275862072.032.980.215635401.44986798CS
      2600.6347.36842105261.337.250.215750232.75061404CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SMCSulliden Mining Capital Inc
      $ 0.02
      (33.33%)
      		5.05k
      FLNTFlint Corporation
      $ 0.025
      (25.00%)
      		40.92k
      CNTCentury Global Commodities Corporation
      $ 0.03
      (20.00%)
      		3k
      APLIAppili Therapeutics Inc
      $ 0.035
      (16.67%)
      		401.3k
      NCFNorthcliff Resources Ltd
      $ 0.035
      (16.67%)
      		1,000
      CRWNCrown Capital Partners Inc
      $ 1.40
      (-24.73%)
      		4.61k
      XTRAXtract One Technologies Inc
      $ 0.53
      (-19.70%)
      		352.94k
      PPRPrairie Provident Resources Inc
      $ 0.03
      (-14.29%)
      		7.85k
      PNPPinetree Capital Ltd
      $ 11.88
      (-13.35%)
      		55.5k
      AVNTAvant Brands Inc
      $ 0.53
      (-13.11%)
      		12.55k
      CNQCanadian Natural Resources Ltd
      $ 45.65
      (-2.12%)
      		19.21M
      BITFBitfarms Ltd
      $ 3.24
      (9.83%)
      		11.15M
      SUSuncor Energy Inc
      $ 54.34
      (-1.11%)
      		10.06M
      TDToronto Dominion Bank
      $ 73.53
      (-0.66%)
      		9.31M
      GWOGreat West Lifeco Inc
      $ 48.76
      (-0.23%)
      		7.15M

      Discussion

      View Full Feed
      glenn1919 glenn1919 1 minute ago
      TSHA.....................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
      TSHA
      glenn1919 glenn1919 2 minutes ago
      FATE...........................https://stockcharts.com/h-sc/ui?s=FATE&p=W&b=5&g=0&id=p86431144783
      FATE
      Kool Aid Man Kool Aid Man 3 minutes ago
      "anyone who didn't sell any from .0005 to .013 is an idiot"...can you provide a single example where you ever shared this prudent wisdom with others as a stock was rising? I know you've said you've cashed out a chunk of your position before...but only AFTER the stock has plunged. Then there's also t
      SPZI
      Lucabazi Lucabazi 4 minutes ago
      What a profound statement. I can see that there was much Due Diligence involved. Thanks for contributing.
      ERHE
      glenn1919 glenn1919 5 minutes ago
      GRI.......................https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p86431144783
      GRI
      glenn1919 glenn1919 8 minutes ago
      ENSC.....................https://stockcharts.com/h-sc/ui?s=ENSC&p=W&b=5&g=0&id=p86431144783
      ENSC
      Guzzi62 Guzzi62 10 minutes ago
      Yes, it's getting old.

      Didn't Les say the company will be very different in the fall?

      If that holds water, something must happen in the next 2 weeks!

      I really hope something will happen before Christmas, but I start to doubt it.
      NWBO
      BDEZ BDEZ 10 minutes ago
      More than 100 teachers in TX are being investigated for their involvement in a massive teacher certification cheating scandal. This cheating scheme affected 21 different school districts

      https://x.com/libsoftiktok/status/1865555132014088311

      Full list below
      dstock07734 dstock07734 10 minutes ago
      That tells us how potent the efficacy of DCVax-L is. Can you believe what would happen if the number of t cells was increased by three or four folds?
      NWBO
      glenn1919 glenn1919 11 minutes ago
      NXTT...........................https://stockcharts.com/h-sc/ui?s=NXTT&p=W&b=5&g=0&id=p86431144783
      NXTT
      PennyHoper PennyHoper 11 minutes ago
      Examples of loosening SEC regulations:
      https://www.securitieslawyer101.com/2024/what-to-expect-from-trumps-sec/
      michael702/ michael702/ 12 minutes ago
      Very Sorry for mistakes on post
      disgusted investor disgusted investor 12 minutes ago
      I mean it must have broken 50 day moving average.
      PKTX
      thistraderknowsall thistraderknowsall 13 minutes ago
      #1 SHPING crypto BREAKOUT to $1+
      Congrats!!
      glenn1919 glenn1919 13 minutes ago
      BBAI.....NVTS......GPUS.............................https://stockcharts.com/h-sc/ui?s=GPUS&p=D&yr=0&mn=2&dy=12&id=p84071410134
      BBAI GPUS NVTS
      jimr1717 jimr1717 14 minutes ago
      “Our existing stockholders will experience Significant Dilution from the sale of our common stock pursuant to this Registration Statement.”

      Don’t get Conned by the CONdog96 🤡™
      ATMH
      cottonmather cottonmather 15 minutes ago
      Syria has fallen. No one certain group has assumed control. There are about five religious groups who will likely fight for control.... ISIS, Alqaeda, etc. Russia and China have abandoned the state. US troops still remain.
      shajandr shajandr 15 minutes ago
      I find this assassination intriguing. I am well-versed in firearms and I am aware of the WW2 Welrod pistol from historical reading, butt I was completely unaware of the B&Y Station Six 9mm (also available in .45ACP) which news sources state retails for $5700 (an INCREDIBLY expensive pistol and only
      BigBadWolf BigBadWolf 15 minutes ago
      Two tools (being facetious) that should never be involved in any trading or investing Egos & Emotions
      $RDARaising Hope Hype & Dreams…now dot the I’s cross all T’s gain OTCIQ access, be transparent w/ your shareholders publish any filings, news & material events
      RDAR
      back2basics back2basics 18 minutes ago
      From the Memorials Board
      --------------------------------------------
      Yesterday, December 7, 1941, is a day that will live in infamy."

      Franklin Delano Roosevelt

      407,000 Americans were KIA, on that day of infamy and in the following years, during World War
      falconer66a falconer66a 18 minutes ago
      But, Do the Molecules Actually Work?

      Frrol, thanks for those important points. Things good to know. Glad you could so clearly state them.

      But, do the Anavex molecules (owned, licensed, or other) actually work? Do they function in diseased cells as I (and Anavex) have c
      AVXL
      MRJ25 MRJ25 18 minutes ago
      If there is a nomination for a new FHFA director, then that will be great news. Regardless of who it is it will be a signal that the new regime is going to deal with this charade.
      FNMA
      WebSlinger WebSlinger 18 minutes ago
      >

      That does seem to partially explain the mistake.
      KBLB
      arizona1 arizona1 19 minutes ago
      https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:m7w6mfn35d53chutrzjzgkng/bafkreiby2stmmt253xz3g74dvecsdy724gfmeegg7f4nlqex3yeywx4ry4@jpeg
      in99flyers in99flyers 19 minutes ago
      1,456,730 holders of shiba. Just checking in on this busy Saturday night to see what progress we made today. Added over 1300 holders since my last post yesterday. I am happy with the progress today . Will update you all tomorrow. Let's grow!
      SHIBUSD

      Your Recent History

      TSX
      MDNA
      Medicenna Therapeutics
      Delayed Upgrade Clock